Highlights and Quick Summary
- Issuance/Purchase of Shares for the quarter ending September 30, 2023 was $0 (a -100.0% decrease compared to previous quarter)
- Year-over-year quarterly Issuance/Purchase of Shares decreased by NaN%
- Annual Issuance/Purchase of Shares for 2022 was $59.4 Million (a 91.14% increase from previous year)
- Annual Issuance/Purchase of Shares for 2021 was $31.1 Million (a 309.61% increase from previous year)
- Annual Issuance/Purchase of Shares for 2020 was $7.58 Million (a -69.97% decrease from previous year)
- Twelve month Issuance/Purchase of Shares ending September 30, 2023 was $40.1 Million (a -0.07% decrease compared to previous quarter)
- Twelve month trailing Issuance/Purchase of Shares increased by 104.7% year-over-year
Trailing Issuance/Purchase of Shares for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Dec '22 | 30 Sep '22 |
|---|---|---|---|
| $40.1 Million | $40.1 Million | $59.4 Million | $19.6 Million |
Visit stockrow.com/ARAV
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Issuance/Purchase of Shares of ARAVIVE, INC
Most recent Issuance/Purchase of Sharesof ARAV including historical data for past 10 years.Interactive Chart of Issuance/Purchase of Shares of ARAVIVE, INC
ARAVIVE, INC Issuance/Purchase of Shares for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $0.0 | $0.03 | – | – | – |
| 2022 | $40.05 | $0.0 | $0.03 | $19.29 | $59.37 |
| 2021 | $0.26 | $0.74 | $1.91 | $28.16 | $31.06 |
| 2020 | $2.35 | $0.2 | $5.0 | $0.03 | $7.58 |
| 2019 | – | $25.24 | $0.0 | $0.01 | $25.25 |
| 2018 | $0.0 | $0.02 | $0.0 | $0.04 | $0.05 |
| 2017 | $0.14 | $0.43 | $1.37 | $1.03 | $2.97 |
| 2016 | $59.35 | $0.04 | $0.41 | $0.0 | $59.81 |
| 2015 | $0.24 | $0.04 | $0.11 | $80.22 | $80.61 |
| 2014 | $0.2 | $0.04 | $-0.09 | $197.56 | $197.7 |
| 2013 | $9.79 | $12.46 | $0.03 | $7.7 | $29.98 |
| 2012 | $6.67 | – | – | – | $6.67 |
Business Profile of ARAVIVE, INC
Sector: Healthcare
Industry: Biotechnology